Update on Ph. Eur. and Pharmeuropa
Recommendation
19/20 November 2024
How to implement EU-GMP Chapter 8
The EDQM recently announced some upcoming changes to the European Pharmacopoeia (Ph. Eur.) and Pharmeuropa.
Shutdown of Ph. Eur. 9th Edition
The Ph. Eur. 9th Edition has been obsolete since January 1, 2020. Consequently, the 9th Edition online and all previous versions, including the Ph. Eur. archives for 9th Edition, will no longer be accessible starting March 1, 2020. The Ph. Eur. 10th Edition and its supplements are available to subscribers on the dedicated Ph. Eur. 10th Edition online platform. Consultation of obsolete Ph. Eur. texts remains possible for users with an up-to-date subscription (i.e. for the 10th Edition) via the Ph. Eur. archive available on the new platform.
More information is available on the Ph. Eur. 10th Edition website.
New Pharmeuropa Website
A new version of the Pharmeuropa website launched on January 24, 2020. Following the update, current Pharmeuropa users will need to register to access the new platform.
According to the announcement, the new Pharmeuropa includes new features, such as
- single sign-on with access to other EDQM websites like Ph. Eur. online and PaedForm;
- improved navigation;
- tablet and smartphone friendly;
- improved search query management;
- a notification tool enabling users to set alerts and receive e-mails when a monograph is added to the “Texts for comment” database, or when a monograph of particular interest is added.
All users will have to register for access, even those who had access to the previous site. Full details on these new features can be found in the Pharmeuropa Online User Manual.
More information is available in the Ph. Eur. Newsroom.
Related GMP News
02.10.2024MHRA: New Rules for Manufacturers and Wholesalers after Brexit
24.09.2024What is RCA (Root Cause Analysis)?
18.09.2024Lack of GMP Training and related Documentation: What Deviations can be found in FDA Warning Letters?
04.09.2024Switzerland: Changes for the Qualification of QPs (Responsible Person; RP in Switzerland)
04.09.2024Insufficient Root Cause Analysis leads to FDA Warning Letter
28.08.2024Switzerland to implement Measures to combat Shortages of Medicines